Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 11, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$14.6B
sum of reported positions
Reported positions
522
Changes vs prior quarter
505
102 new · 66 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 161 measured positions in 8 quarters, the typical new or larger position finished −2.3 pts against the S&P 500 and 42% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
TEVA PHARMACEUTICAL INDS LTD | 42.9M | $1.45B | 9.9% |
| 3.51M | $914M | 6.2% | |
SELECT SECTOR SPDR TR | 4.23M | $784M | 5.4% |
ISHARES TR | 4.01M | $579M | 4.0% |
| 1.16M | $553M | 3.8% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $10.5B | $14.6B |
| Positions | 486 | 522 |
| Biggest line | — | TEVA PHARMACEUTICAL INDS LTD 10% |
INVESCO EXCHANGE TRADED FD T |
| 2.31M |
| $491M |
| 3.4% |
| 2.31M | $461M | 3.2% |
| 1.46M | $349M | 2.4% |
| 618K | $335M | 2.3% |
VANGUARD SCOTTSDALE FDS | 3.04M | $323M | 2.2% |
ISHARES TR | 1.28M | $310M | 2.1% |
| 862K | $305M | 2.1% |
| 390K | $297M | 2.0% |
| 795K | $296M | 2.0% |
ISHARES TR | 2.68M | $264M | 1.8% |
| 751K | $256M | 1.7% |
| 646K | $244M | 1.7% |
ISHARES TR | 1.51M | $237M | 1.6% |
| 695K | $201M | 1.4% |
| 808K | $198M | 1.4% |
| 1.37M | $196M | 1.3% |
| 2.08M | $190M | 1.3% |
SELECT SECTOR SPDR TR | 988K | $188M | 1.3% |
| 5.37M | $187M | 1.3% |
ISHARES INC | 4.99M | $172M | 1.2% |
Southern Copper Corp/ (SCCO)
1,924 shares
Dover Corporation (DOV)
1,357 → 1,473 shares (+9%)
Lennar (LEN)
3,659 shares
T1 Energy (TE)
35K shares
INNOVATOR ETFS TRUST
8,055 → 6,765 shares (−16%)
HP Inc. (HPQ)
15K shares
GE HealthCare (GEHC)
4,498 → 5,131 shares (+14%)
Nokia (NOK)
25K shares
Ke (BEKE)
23K shares
Royal Gold (RGLD)
1,624 shares
INNOVATOR ETFS TRUST
14K → 11K shares (−22%)
RenaissanceRe (RNR)
997 shares
Equitable Holdings (EQH)
7,200 shares
Biogen (BIIB)
1,371 → 1,457 shares (+6%)
Dexcom (DXCM)
3,878 → 4,660 shares (+20%)
Otis Worldwide (OTIS)
3,977 → 4,333 shares (+9%)
ResMed| (RMD)
1,402 → 1,591 shares (+14%)
GameStop (GME)
14K shares
Host Hotels & Resorts (HST)
13K shares
HF Sinclair (DINO)
4,432 shares
Xylem Inc. (XYL)
4,749 → 2,591 shares (−45%)
Copart (CPRT)
9,513 → 11K shares (+14%)
Lockheed Martin (LMT)
1,206 → 600 shares (−50%)
INNOVATOR ETFS TRUST
11K → 9,920 shares (−8%)
Curtiss-Wright (CW)
400 shares
